Highly Potent Statin Stands Out for Diabetes, Cataract Risks
(MedPage Today) -- Two high-intensity statin regimens showed similar clinical efficacy when directly compared in secondary prevention, but one was associated with a greater risk of diabetes and cataracts in results from the LODESTAR trial.
Whether...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Cataracts | Cholesterol | Diabetes | Endocrinology | Heart | Statin Therapy